ibritumomab (Q635415)

From Wikidata
Jump to navigation Jump to search
radioimmunotherapy treatment
  • Ig gamma-2A chain C region, membrane-bound form
  • radiolabeled murine anti-CD20
edit
Language Label Description Also known as
English
ibritumomab
radioimmunotherapy treatment
  • Ig gamma-2A chain C region, membrane-bound form
  • radiolabeled murine anti-CD20

Statements

canonical SMILES
CC(CN(CC(CC1=CC=C(C=C1)NC(=O)NC)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O
reason for deprecated rank
incorrect structure of molecular entity
1 reference
stated in
PubChem
PubChem CID
74890578
language of work or name
English
title
Ibritumomab tiuxetan (English)
retrieved
21 September 2016
isomeric SMILES
CC(CN(C[C@H](CC1=CC=C(C=C1)NC(=O)NC)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O
reason for deprecated rank
incorrect structure of molecular entity
1 reference
stated in
PubChem
PubChem CID
74890578
language of work or name
English
title
Ibritumomab tiuxetan (English)
retrieved
21 September 2016
World Health Organisation international non-proprietary name
ibritumomab tiuxetan (English)
0 references
ibritumomab tiuxétan (French)
0 references
ibritumomab tiuxetán (Spanish)
0 references
ибритумомаб тиуксетан (Russian)
0 references
إيبريتوموماب تيوكسيتان (Arabic)
0 references
替伊莫单抗 (Chinese)
0 references

Identifiers

ChemSpider ID
57269045
reason for deprecated rank
incorrect structure of molecular entity
1 reference
stated in
ChemSpider
ChemSpider ID
57269045
language of work or name
English
title
N-[(2S)-2-[Bis(carboxymethyl)amino]-3-(4-{[hydroxy(methylimino)methyl]amino}phenyl)propyl]-N-{2-[bis(carboxymethyl)amino]propyl}glycine (English)
retrieved
21 September 2016
ATC code
V10XX02
0 references
DrugBank ID
DB00078
0 references
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  Retrieved from "https://www.wikidata.org/w/index.php?title=Q635415&oldid=2190034589"